Gordon Sze, MD
Professor Emeritus of Radiology and Biomedical Imaging
Research & Publications
Biography
News
Research Summary
My research interests in Neuroradiology are broad and include pediatrics, brain, and spine diseases.
Coauthors
Selected Publications
- Low-field, Portable Magnetic Resonance Imaging to Assess Hematoma Volume in Traumatic Brain Injury Patients (P10-5.008)Zabinska J, Yadlapalli V, Mazurek M, Parasuram N, Lalwani D, Peasley E, Gilmore E, Kim J, Omay S, Sze G, Payabvash S, Sorby-Adams A, Iglesias J, Rosen M, Kimberly W, Sheth K. Low-field, Portable Magnetic Resonance Imaging to Assess Hematoma Volume in Traumatic Brain Injury Patients (P10-5.008). Neurology 2024, 102 DOI: 10.1212/wnl.0000000000208210.
- Abstract 89: Portable, Low-Field Magnetic Resonance Imaging: Determining Mismatch Following Acute Ischemic StrokeSorby-Adams A, Guo J, Schleicher R, Mazurek M, Baldassano S, Payavbash S, Sze G, Schindler J, de Havenon A, Goldstein J, Schaefer P, Zabinska J, Lalwani D, Wira C, Matouk C, Lee V, Muir K, Nimjee S, Pinter N, Siddiqui A, Kirsch J, Iglesias J, Rosen M, Sheth K, Kimberly W. Abstract 89: Portable, Low-Field Magnetic Resonance Imaging: Determining Mismatch Following Acute Ischemic Stroke. Stroke 2024, 55 DOI: 10.1161/str.55.suppl_1.89.
- Low-Field, Portable Magnetic Resonance Imaging at the Bedside to Assess Brain Injury in Patients with Severe COVID-19 (1349)Mazurek M, Yuen M, Cahn B, Rosen M, Gobeske K, Gilmore E, Hwang D, Kaddouh F, Kim J, Falcone G, Petersen N, Siner J, Spudich S, Sze G, Kimberly W, Sheth K. Low-Field, Portable Magnetic Resonance Imaging at the Bedside to Assess Brain Injury in Patients with Severe COVID-19 (1349). Neurology 2021, 96 DOI: 10.1212/wnl.96.15_supplement.1349.
- Deployment of Portable, Bedside, Low-field Magnetic Resonance Imaging for Evaluation of Stroke Patients (272)Cahn B, Shah J, Dyvorne H, O’Halloran R, Poole M, Yuen M, Mazurek M, Ward A, Payabvash S, Beekman R, Brown S, Falcone G, Gobeske K, Petersen N, Jasne A, Sharma R, Schindler J, Sansing L, Gilmore E, Wira C, Matouk C, Sze G, Rosen M, Kimberly W, Sheth K. Deployment of Portable, Bedside, Low-field Magnetic Resonance Imaging for Evaluation of Stroke Patients (272). Neurology 2020, 94 DOI: 10.1212/wnl.94.15_supplement.272.
- Apparent Diffusion Coefficient Value Changes and Clinical Correlation in 90 Cases of Cytomegalovirus-Infected Fetuses with Unremarkable Fetal MRI ResultsKotovich D, Guedalia JSB, Hoffmann C, Sze G, Eisenkraft A, Yaniv G. Apparent Diffusion Coefficient Value Changes and Clinical Correlation in 90 Cases of Cytomegalovirus-Infected Fetuses with Unremarkable Fetal MRI Results. American Journal Of Neuroradiology 2017, 38: 1443-1448. PMID: 28522662, PMCID: PMC7959907, DOI: 10.3174/ajnr.a5222.
- Long Term Outcomes of IV Glyburide In Patients 70 Years of Age or Under: Subgroup Analysis from the Phase II GAMES-RP Study of Patients with Large Hemispheric Infarction (S29.008)Sheth K, Cheung K, Elm J, Hinson H, Molyneaux B, Beslow L, Sze G, Ostwaldt A, Kimberly W. Long Term Outcomes of IV Glyburide In Patients 70 Years of Age or Under: Subgroup Analysis from the Phase II GAMES-RP Study of Patients with Large Hemispheric Infarction (S29.008). Neurology 2017, 88 DOI: 10.1212/wnl.88.16_supplement.s29.008.
- GAMES (Glyburide Advantage in Malignant Edema and Stroke) RP: A Phase II Study Toward Preventing Edema After Ischemia (I11.006)Sheth K, Elm J, Hinson H, Molyneaux B, Beslow L, Sze G, Ostwaldt A, Del Zoppo G, Simard J, Jacobson S, Kimberly W. GAMES (Glyburide Advantage in Malignant Edema and Stroke) RP: A Phase II Study Toward Preventing Edema After Ischemia (I11.006). Neurology 2016, 86 DOI: 10.1212/wnl.86.16_supplement.i11.006.
- GAMES (Glyburide Advantage in Malignant Edema and Stroke) RP Trial: Intermediate Endpoint Analysis as Proof-Of-Concept (I11.010)Kimberly W, Elm J, Hinson H, Molyneaux B, Beslow L, Sze G, Ostwaldt A, Del Zoppo G, Simard M, Sheth K. GAMES (Glyburide Advantage in Malignant Edema and Stroke) RP Trial: Intermediate Endpoint Analysis as Proof-Of-Concept (I11.010). Neurology 2016, 86 DOI: 10.1212/wnl.86.16_supplement.i11.010.
- GAMES (Glyburide Advantage in Malignant Edema and Stroke) RP: A Phase II Study Toward Preventing Edema After Ischemia (S7.004)Sheth K, Elm J, Hinson H, Molyneaux B, Beslow L, Sze G, Ostwaldt A, Del Zoppo G, Simard J, Jacobson S, Kimberly W. GAMES (Glyburide Advantage in Malignant Edema and Stroke) RP: A Phase II Study Toward Preventing Edema After Ischemia (S7.004). Neurology 2016, 86 DOI: 10.1212/wnl.86.16_supplement.s7.004.
- GAMES (Glyburide Advantage in Malignant Edema and Stroke) RP Trial: Intermediate Endpoint Analysis as Proof-Of-Concept (S7.006)Kimberly W, Elm J, Hinson H, Molyneaux B, Beslow L, Sze G, Ostwaldt A, Del Zoppo G, Simard M, Sheth K. GAMES (Glyburide Advantage in Malignant Edema and Stroke) RP Trial: Intermediate Endpoint Analysis as Proof-Of-Concept (S7.006). Neurology 2016, 86 DOI: 10.1212/wnl.86.16_supplement.s7.006.
- Prenatal stress alters amygdala functional connectivity in preterm neonatesScheinost D, Kwon SH, Lacadie C, Sze G, Sinha R, Constable RT, Ment LR. Prenatal stress alters amygdala functional connectivity in preterm neonates. NeuroImage Clinical 2016, 12: 381-388. PMID: 27622134, PMCID: PMC5009231, DOI: 10.1016/j.nicl.2016.08.010.
- Glyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial: Rationale and DesignSheth KN, Elm JJ, Beslow LA, Sze GK, Kimberly WT. Glyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial: Rationale and Design. Neurocritical Care 2015, 24: 132-139. PMID: 26268138, DOI: 10.1007/s12028-015-0189-7.